It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
HIV positive key population (KP) often face health system and social barriers to HIV care. KP include sex workers, men who have sex with men, persons who inject drugs, transgender people, and people in prisons and other closed settings. Community-based ART service delivery (CBART) has the potential to increase access to antiretroviral treatment (ART) and enhance retention in care. This scoping review summarized the evidence on the effect of CBART along the continuum of HIV care among KP in sub-Saharan Africa. We searched Pubmed, Web of Science, Google scholar, and NGO websites for articles published between 2010 and April 2020. We synthesized the involvement of KP community members or lay providers in medical task provision, and outcomes along the continuum of HIV care. Of 3,330 records identified, 66 were eligible for full test screening, out of which 12 were included in the review. CBART for KP was provided through: (a) community drop-in-centres, (b) community drop-in-centres plus mobile team, or (c) community-based health centres. KP were engaged as peer educators and they provided services such as community mobilisation activities for HIV testing and ART, ART adherence counselling, and referral for ART initiation. Across the KP-CBART studies, outcomes in terms of ART uptake, adherence to ART, retention in care and viral suppression were at least as good as those obtained for KP attending facility-based care. KP-CBART was as effective as facility-based care. To achieve the UNAIDS 95–95–95 target in sub-Saharan Africa, national programmes should scale-up KP-CBART to complement facility-based care.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Institute of Tropical Medicine, Antwerp, Belgium (GRID:grid.11505.30) (ISNI:0000 0001 2153 5088); APIN Public Health Initiatives, Abuja, Nigeria (GRID:grid.432902.e); University of Antwerp, Antwerp, Belgium (GRID:grid.5284.b) (ISNI:0000 0001 0790 3681)
2 University of Antwerp, Antwerp, Belgium (GRID:grid.5284.b) (ISNI:0000 0001 0790 3681)
3 APIN Public Health Initiatives, Abuja, Nigeria (GRID:grid.432902.e)
4 Institute of Tropical Medicine, Antwerp, Belgium (GRID:grid.11505.30) (ISNI:0000 0001 2153 5088)
5 Institute of Tropical Medicine, Antwerp, Belgium (GRID:grid.11505.30) (ISNI:0000 0001 2153 5088); Research Foundation Flanders, Brussels, Belgium (GRID:grid.434261.6) (ISNI:0000 0000 8597 7208)